TITLE

editor's message. GE Ventilator Getting Closer to US Approval

AUTHOR(S)
Fratantoro, Mike
PUB. DATE
April 2015
SOURCE
RT: The Journal for Respiratory Care Practitioners;Apr2015, Vol. 28 Issue 4, p4
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The author offers observation on GE Healthcare's critical care ventilator, the Carescape R860. Topics discussed include the functions of the device, the two key objectives addressed by the ventilator in improving patient outcomes and increase the ease of use for clinicians, and statement from Matti Lehtonen of GE Healthcare on the public's response to the ventilator.
ACCESSION #
103016446

 

Related Articles

  • Alphatec Spine receives FDA, Japanese clearances.  // Medical Device Daily;1/ 4/2013, Vol. 17 Issue 3, p9 

    The article reports that the device company Alphatec Spine has received clearances from the U.S. Food and Drugs Administration (FDA) and Pharmaceuticals and Medical Devices Agency in Japan for the company's product commercialization strategy.

  • Crosstrees gains FDA clearance for PVA device. FORD, OMAR // Medical Device Daily;9/20/2013, Vol. 17 Issue 182, p1 

    The article reports that the U.S. Food and Drug Administration (FDA) has granted medical device maker Crosstrees Medical a 510(k) clearance for the Crosstrees PVA Pod System for Percutaneous Vertebral Augmentation (PVA). The clearance was obtained after the Crosstrees procedure demonstrated in a...

  • Orbital implant receives 510(k) clearance.  // Ocular Surgery News;1/25/2012, Vol. 30 Issue 2, p36 

    The article reports on the 510(k) clearance received by Ceramisys' Orbtex ceramic orbital implant from the U.S. Food and Drug Administration.

  • Reverse gains clearance for MVP-5 plug system. Ford, Omar // Medical Device Daily;12/12/2013, Vol. 17 Issue 239, p1 

    The article reports that medical device developer Reverse Medical earned commercialization clearance from the U.S. Food and Drug Administration (FDA) for the MVP-5 Micro Vascular Plug system it developed for peripheral vessel embolization. Company chief executive officer (CEO) Jeffery Valkro...

  • Users of retinal prosthesis system accumulate implant time since FDA approval.  // Ocular Surgery News;2/25/2014, Vol. 32 Issue 4, p32 

    The article reports that 35 subjects have been implanted with the Argus II device, which is also known as the Second Sight, since the U.S. Food and Drug Administration has approved the Argus II retinal prosthesis system according to Dr. Mark S. Humayun, co-inventor of the Argus II device.

  • Children’s prosthetic thoracic device passes FDA postmarket review. FOXHALL, KATHRYN // Contemporary Pediatrics;May2014, Vol. 31 Issue 5, p5 

    The article reports that the Vertical Expandable Prosthetic Titanium Rib (VEPTR), a surgically implanted device to treat thoracic insufficiency syndrome in children, passed postmarket review by U.S. Food and Drug Administration (FDA) Pediatric Advisory Committee in April 2014. Topics discussed...

  • The FDA approval process for medical devices: an inherently flawed system or a valuable pathway for innovation? Fargen, Kyle M.; Frei, Donald; Fiorella, David; McDougall, Cameron G.; Myers, Philip M.; Hirsch, Joshua A.; Mocco, J. // Journal of NeuroInterventional Surgery;Jul2013, Vol. 5 Issue 4, p269 

    The article presents a commentary on the approval process being used by the U.S. Food and Drug Administration (FDA) for medical devices. Manufacturers are urging the FDA to streamline the lengthy approval process. Some approved devices that have generated controversy because of their failure are...

  • Product Changes and the 510(k). Lincoln, John E. // Journal of Validation Technology;Winter2011, Vol. 17 Issue 1, p40 

    The article looks at the changes under the 510(k). It points out that the cumulative effect of multiple minor changes may compel a manufacturer to regard that a device has been significantly changed. The U.S. Food and Drug Administration will not require a new submission for every change but...

  • FDA panel recommends premarket approval application for AcrySof IQ ReSTOR multifocal toric IOL.  // Ocular Surgery News;12/10/2014, Vol. 32 Issue 23, p31 

    The article reports that the Ophthalmic Devices Panel of the Medical Devices Advisory Committee of the U.S. Food and Drug Administration (FDA) voted to recommend premarket approval application for AcrySof IQ ReSTOR +3.0 multifocal toric intraocular lens (IOL) of medical company Alcon.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics